AgingResearch.NewsJoin free

Brenus Pharma

CompanyFrance

Brenus Pharma develops one asset, in phase 1 (STC-1010 in microsatellite stable metastatic colorectal cancer). Mostly vaccine; based in France.

1
Asset
Furthest stage
Phase 1
Raised
€11M
0
Trials
0
Signals

Pipeline

1

  • STC-1010

    Engages dendritic cells in vivo to activate antitumor T-cell responses.

    Phase 1, Vaccine, microsatellite stable metastatic colorectal cancer

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Funding rounds and grants1
  • Signals1

Intelligence